Review



mertk sirna  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Santa Cruz Biotechnology mertk sirna
    Mertk Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mertk+sirna/pm40249148-70-8-19?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 9 article reviews
    mertk sirna - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    99
    Thermo Fisher oligo targeting mertk
    Oligo Targeting Mertk, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mertk+sirna/pmc12519743__12933_2025_2965_MOESM1_ESM-35-15-22?v=Thermo+Fisher
    Average 99 stars, based on 1 article reviews
    oligo targeting mertk - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology mertk sirna
    Mertk Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mertk+sirna/pm40249148-70-8-19?v=Santa+Cruz+Biotechnology
    Average 93 stars, based on 1 article reviews
    mertk sirna - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    Sangon Biotech sirnas targeting mertk
    Functional assays of <t>MERTK</t> in cervical cancer cells. ( A ) mRNA levels following MERTK knockdown with siRNA(n=3). ( B ) Assessment of the impact of MERTK knockdown on the proliferation capacity of cervical cancer cells using the MTS assay(n=3). ( C ) Evaluation of the migratory ability of SiHa and HeLa cells following low expression of MERTK through a scratch assay(n=3). ( D ) Assessment of the effects of MERTK silencing on the migratory and invasive capabilities of cervical cancer cells using transwell migration and invasion assays(n=3). Data are presented as mean±SD. (** p < 0.01, *** p < 0.001, **** p < 0.0001).
    Sirnas Targeting Mertk, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mertk+sirna/pmc12124307-106-6-11?v=Sangon+Biotech
    Average 90 stars, based on 1 article reviews
    sirnas targeting mertk - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Bioneer Corporation sirnas targeting mertk and axl and the negative control
    Functional assays of <t>MERTK</t> in cervical cancer cells. ( A ) mRNA levels following MERTK knockdown with siRNA(n=3). ( B ) Assessment of the impact of MERTK knockdown on the proliferation capacity of cervical cancer cells using the MTS assay(n=3). ( C ) Evaluation of the migratory ability of SiHa and HeLa cells following low expression of MERTK through a scratch assay(n=3). ( D ) Assessment of the effects of MERTK silencing on the migratory and invasive capabilities of cervical cancer cells using transwell migration and invasion assays(n=3). Data are presented as mean±SD. (** p < 0.01, *** p < 0.001, **** p < 0.0001).
    Sirnas Targeting Mertk And Axl And The Negative Control, supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mertk+sirna/pmc09534909-95-7-17?v=Bioneer+Corporation
    Average 90 stars, based on 1 article reviews
    sirnas targeting mertk and axl and the negative control - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Ribobio co sirnas for mertk and cct5
    MERTK siRNA downregulated the expression of <t>CCT5,</t> which interacted and co-localized with F-actin in HsRPE cells. (A) HsRPE cells were treated with NC or MERTK siRNA for 24 h, and the expression of F-actin was analyzed by RT-PCR. (B) HsRPE cells were treated with NC or MERTK siRNA for 48 h, and the expression of F-actin was analyzed by Western blotting. (C) HsRPE cells were treated the same as in (B) , and the distribution and organization of F-actin (green) were detected by immunofluorescence analysis. Scale bars: 10 μm. (D) HsRPE cells were treated the same as in (A), and CCT5 expression was analyzed by RT-PCR. (E) HsRPE cells were treated the same as in (B) , and CCT5 expression was analyzed by Western blotting. (F) The co-localization (yellow) of F-actin (red) and CCT5 (green) in HsRPE cells was assessed by immunolocalization analysis. Scale bars: 10 μm. (G) The binding between F-actin and CCT5 in HsRPE cells was verified by co-immunoprecipitation. (H) The binding between MERTK and CCT5 in HsRPE cells was verified by co-immunoprecipitation. ** P < 0.01; *** P < 0.001.
    Sirnas For Mertk And Cct5, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mertk+sirna/pmc09043132-196-5-11?v=Ribobio+co
    Average 90 stars, based on 1 article reviews
    sirnas for mertk and cct5 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Beyotime mertk sirna
    MERTK siRNA downregulated the expression of <t>CCT5,</t> which interacted and co-localized with F-actin in HsRPE cells. (A) HsRPE cells were treated with NC or MERTK siRNA for 24 h, and the expression of F-actin was analyzed by RT-PCR. (B) HsRPE cells were treated with NC or MERTK siRNA for 48 h, and the expression of F-actin was analyzed by Western blotting. (C) HsRPE cells were treated the same as in (B) , and the distribution and organization of F-actin (green) were detected by immunofluorescence analysis. Scale bars: 10 μm. (D) HsRPE cells were treated the same as in (A), and CCT5 expression was analyzed by RT-PCR. (E) HsRPE cells were treated the same as in (B) , and CCT5 expression was analyzed by Western blotting. (F) The co-localization (yellow) of F-actin (red) and CCT5 (green) in HsRPE cells was assessed by immunolocalization analysis. Scale bars: 10 μm. (G) The binding between F-actin and CCT5 in HsRPE cells was verified by co-immunoprecipitation. (H) The binding between MERTK and CCT5 in HsRPE cells was verified by co-immunoprecipitation. ** P < 0.01; *** P < 0.001.
    Mertk Sirna, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mertk+sirna/pm34185276-72-1-8?v=Beyotime
    Average 90 stars, based on 1 article reviews
    mertk sirna - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Shanghai GenePharma mertk-sirna
    MERTK siRNA downregulated the expression of <t>CCT5,</t> which interacted and co-localized with F-actin in HsRPE cells. (A) HsRPE cells were treated with NC or MERTK siRNA for 24 h, and the expression of F-actin was analyzed by RT-PCR. (B) HsRPE cells were treated with NC or MERTK siRNA for 48 h, and the expression of F-actin was analyzed by Western blotting. (C) HsRPE cells were treated the same as in (B) , and the distribution and organization of F-actin (green) were detected by immunofluorescence analysis. Scale bars: 10 μm. (D) HsRPE cells were treated the same as in (A), and CCT5 expression was analyzed by RT-PCR. (E) HsRPE cells were treated the same as in (B) , and CCT5 expression was analyzed by Western blotting. (F) The co-localization (yellow) of F-actin (red) and CCT5 (green) in HsRPE cells was assessed by immunolocalization analysis. Scale bars: 10 μm. (G) The binding between F-actin and CCT5 in HsRPE cells was verified by co-immunoprecipitation. (H) The binding between MERTK and CCT5 in HsRPE cells was verified by co-immunoprecipitation. ** P < 0.01; *** P < 0.001.
    Mertk Sirna, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mertk+sirna/pm32747017-52-0-13?v=Shanghai+GenePharma
    Average 90 stars, based on 1 article reviews
    mertk-sirna - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    93
    OriGene sirna 27 mer duplexes
    MERTK siRNA downregulated the expression of <t>CCT5,</t> which interacted and co-localized with F-actin in HsRPE cells. (A) HsRPE cells were treated with NC or MERTK siRNA for 24 h, and the expression of F-actin was analyzed by RT-PCR. (B) HsRPE cells were treated with NC or MERTK siRNA for 48 h, and the expression of F-actin was analyzed by Western blotting. (C) HsRPE cells were treated the same as in (B) , and the distribution and organization of F-actin (green) were detected by immunofluorescence analysis. Scale bars: 10 μm. (D) HsRPE cells were treated the same as in (A), and CCT5 expression was analyzed by RT-PCR. (E) HsRPE cells were treated the same as in (B) , and CCT5 expression was analyzed by Western blotting. (F) The co-localization (yellow) of F-actin (red) and CCT5 (green) in HsRPE cells was assessed by immunolocalization analysis. Scale bars: 10 μm. (G) The binding between F-actin and CCT5 in HsRPE cells was verified by co-immunoprecipitation. (H) The binding between MERTK and CCT5 in HsRPE cells was verified by co-immunoprecipitation. ** P < 0.01; *** P < 0.001.
    Sirna 27 Mer Duplexes, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mertk+sirna/pmc08144930-74-1-22?v=OriGene
    Average 93 stars, based on 1 article reviews
    sirna 27 mer duplexes - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    Functional assays of MERTK in cervical cancer cells. ( A ) mRNA levels following MERTK knockdown with siRNA(n=3). ( B ) Assessment of the impact of MERTK knockdown on the proliferation capacity of cervical cancer cells using the MTS assay(n=3). ( C ) Evaluation of the migratory ability of SiHa and HeLa cells following low expression of MERTK through a scratch assay(n=3). ( D ) Assessment of the effects of MERTK silencing on the migratory and invasive capabilities of cervical cancer cells using transwell migration and invasion assays(n=3). Data are presented as mean±SD. (** p < 0.01, *** p < 0.001, **** p < 0.0001).

    Journal: International Journal of Women's Health

    Article Title: The Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with Experimental Validation

    doi: 10.2147/IJWH.S516444

    Figure Lengend Snippet: Functional assays of MERTK in cervical cancer cells. ( A ) mRNA levels following MERTK knockdown with siRNA(n=3). ( B ) Assessment of the impact of MERTK knockdown on the proliferation capacity of cervical cancer cells using the MTS assay(n=3). ( C ) Evaluation of the migratory ability of SiHa and HeLa cells following low expression of MERTK through a scratch assay(n=3). ( D ) Assessment of the effects of MERTK silencing on the migratory and invasive capabilities of cervical cancer cells using transwell migration and invasion assays(n=3). Data are presented as mean±SD. (** p < 0.01, *** p < 0.001, **** p < 0.0001).

    Article Snippet: Dilute small interfering RNAs (siRNAs) targeting MERTK (si-MERTK) and SERPINF1 (si-SERPINF1) (Sangon Biotech, China) in Opti-MEM Medium, adjusting the siRNA concentration to 0.2 pmol/μL.

    Techniques: Functional Assay, Knockdown, MTS Assay, Expressing, Wound Healing Assay, Migration

    GSEA enrichment analysis of MERTK and SERPINF1 expression levels. ( A ) GO enrichment analysis in high SERPINF1 group. ( B ) GO enrichment analysis in low SERPINF1 group. ( C ) KEGG enrichment analysis in high SERPINF1 group. ( D ) KEGG enrichment analysis in low SERPINF1 group. ( E ) GO enrichment analysis in high MERTK group. ( F ) GO enrichment analysis in low MERTK group. ( G ) KEGG enrichment analysis in high MERTK group.

    Journal: International Journal of Women's Health

    Article Title: The Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with Experimental Validation

    doi: 10.2147/IJWH.S516444

    Figure Lengend Snippet: GSEA enrichment analysis of MERTK and SERPINF1 expression levels. ( A ) GO enrichment analysis in high SERPINF1 group. ( B ) GO enrichment analysis in low SERPINF1 group. ( C ) KEGG enrichment analysis in high SERPINF1 group. ( D ) KEGG enrichment analysis in low SERPINF1 group. ( E ) GO enrichment analysis in high MERTK group. ( F ) GO enrichment analysis in low MERTK group. ( G ) KEGG enrichment analysis in high MERTK group.

    Article Snippet: Dilute small interfering RNAs (siRNAs) targeting MERTK (si-MERTK) and SERPINF1 (si-SERPINF1) (Sangon Biotech, China) in Opti-MEM Medium, adjusting the siRNA concentration to 0.2 pmol/μL.

    Techniques: Expressing

    Sensitivity analysis of MERTK and SERPINF1 to commonly used anti-cervical cancer drugs. ( A ) Sensitivity correlation analysis of MERTK and Irinotecan. ( B ) Sensitivity correlation analysis of MERTK and Temsirolimus. ( C ) Sensitivity correlation analysis of MERTK and Topotecan. ( D ) Sensitivity correlation analysis of SERPINF1 and 5-Fluorouracil. ( E ) Sensitivity correlation analysis of SERPINF1 and Paclitaxel. ( F ) Sensitivity correlation analysis of SERPINF1 and Piperlongumine. ( G ) Sensitivity correlation analysis of SERPINF1 and Vinblastine.

    Journal: International Journal of Women's Health

    Article Title: The Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with Experimental Validation

    doi: 10.2147/IJWH.S516444

    Figure Lengend Snippet: Sensitivity analysis of MERTK and SERPINF1 to commonly used anti-cervical cancer drugs. ( A ) Sensitivity correlation analysis of MERTK and Irinotecan. ( B ) Sensitivity correlation analysis of MERTK and Temsirolimus. ( C ) Sensitivity correlation analysis of MERTK and Topotecan. ( D ) Sensitivity correlation analysis of SERPINF1 and 5-Fluorouracil. ( E ) Sensitivity correlation analysis of SERPINF1 and Paclitaxel. ( F ) Sensitivity correlation analysis of SERPINF1 and Piperlongumine. ( G ) Sensitivity correlation analysis of SERPINF1 and Vinblastine.

    Article Snippet: Dilute small interfering RNAs (siRNAs) targeting MERTK (si-MERTK) and SERPINF1 (si-SERPINF1) (Sangon Biotech, China) in Opti-MEM Medium, adjusting the siRNA concentration to 0.2 pmol/μL.

    Techniques:

    MERTK siRNA downregulated the expression of CCT5, which interacted and co-localized with F-actin in HsRPE cells. (A) HsRPE cells were treated with NC or MERTK siRNA for 24 h, and the expression of F-actin was analyzed by RT-PCR. (B) HsRPE cells were treated with NC or MERTK siRNA for 48 h, and the expression of F-actin was analyzed by Western blotting. (C) HsRPE cells were treated the same as in (B) , and the distribution and organization of F-actin (green) were detected by immunofluorescence analysis. Scale bars: 10 μm. (D) HsRPE cells were treated the same as in (A), and CCT5 expression was analyzed by RT-PCR. (E) HsRPE cells were treated the same as in (B) , and CCT5 expression was analyzed by Western blotting. (F) The co-localization (yellow) of F-actin (red) and CCT5 (green) in HsRPE cells was assessed by immunolocalization analysis. Scale bars: 10 μm. (G) The binding between F-actin and CCT5 in HsRPE cells was verified by co-immunoprecipitation. (H) The binding between MERTK and CCT5 in HsRPE cells was verified by co-immunoprecipitation. ** P < 0.01; *** P < 0.001.

    Journal: Frontiers in Medicine

    Article Title: Chaperonin-Containing TCP1 Subunit 5 Protects Against the Effect of Mer Receptor Tyrosine Kinase Knockdown in Retinal Pigment Epithelial Cells by Interacting With Filamentous Actin and Activating the LIM-Kinase 1/Cofilin Pathway

    doi: 10.3389/fmed.2022.861371

    Figure Lengend Snippet: MERTK siRNA downregulated the expression of CCT5, which interacted and co-localized with F-actin in HsRPE cells. (A) HsRPE cells were treated with NC or MERTK siRNA for 24 h, and the expression of F-actin was analyzed by RT-PCR. (B) HsRPE cells were treated with NC or MERTK siRNA for 48 h, and the expression of F-actin was analyzed by Western blotting. (C) HsRPE cells were treated the same as in (B) , and the distribution and organization of F-actin (green) were detected by immunofluorescence analysis. Scale bars: 10 μm. (D) HsRPE cells were treated the same as in (A), and CCT5 expression was analyzed by RT-PCR. (E) HsRPE cells were treated the same as in (B) , and CCT5 expression was analyzed by Western blotting. (F) The co-localization (yellow) of F-actin (red) and CCT5 (green) in HsRPE cells was assessed by immunolocalization analysis. Scale bars: 10 μm. (G) The binding between F-actin and CCT5 in HsRPE cells was verified by co-immunoprecipitation. (H) The binding between MERTK and CCT5 in HsRPE cells was verified by co-immunoprecipitation. ** P < 0.01; *** P < 0.001.

    Article Snippet: The siRNAs for MERTK and CCT5 were designed and synthesized by RiboBio Inc. (Guangzhou, China).

    Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Western Blot, Immunofluorescence, Binding Assay, Immunoprecipitation

    Upregulation of CCT5 expression recovered the morphology and migration function disrupted by MERTK siRNA in HsRPE cells. (A) HsRPE cells were treated with NC, CCT5 siRNA1, or CCT5 siRNA2 (20 nM) for 24 h, and CCT5 expression was analyzed by RT-PCR. (B) HsRPE cells were treated with or without CCT5 siRNA or CCT5 -specific lentiviral vectors ( CCT5 -Le) after exposure to NC or MERTK siRNA for 24 h, and the expression of CCT5 was analyzed by RT-PCR. (C) HsRPE cells were treated with or without CCT5 siRNA or CCT5 -specific lentiviral vectors ( CCT5 -Le) after exposure to NC or MERTK siRNA for 48 h, and CCT5 expression was analyzed by Western blotting. (D) HsRPE cells were treated the same as in (C), and cell proliferation was determined by CCK8 assay. (E) HsRPE cells were treated the same as in (C) , and morphological changes were observed using an inverted microscope. Scale bars: 100 μm. (F) HsRPE cells were treated the same as in (C) , and wound-healing assays were performed to assess the wound-healing capabilities of HsRPE cells. Scale bars: 200 μm. (G) HsRPE cells were treated the same as in (C) , and Transwell assays were performed to evaluate the migration activity of HsRPE cells (purple). Scale bars: 100 μm. # P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001.

    Journal: Frontiers in Medicine

    Article Title: Chaperonin-Containing TCP1 Subunit 5 Protects Against the Effect of Mer Receptor Tyrosine Kinase Knockdown in Retinal Pigment Epithelial Cells by Interacting With Filamentous Actin and Activating the LIM-Kinase 1/Cofilin Pathway

    doi: 10.3389/fmed.2022.861371

    Figure Lengend Snippet: Upregulation of CCT5 expression recovered the morphology and migration function disrupted by MERTK siRNA in HsRPE cells. (A) HsRPE cells were treated with NC, CCT5 siRNA1, or CCT5 siRNA2 (20 nM) for 24 h, and CCT5 expression was analyzed by RT-PCR. (B) HsRPE cells were treated with or without CCT5 siRNA or CCT5 -specific lentiviral vectors ( CCT5 -Le) after exposure to NC or MERTK siRNA for 24 h, and the expression of CCT5 was analyzed by RT-PCR. (C) HsRPE cells were treated with or without CCT5 siRNA or CCT5 -specific lentiviral vectors ( CCT5 -Le) after exposure to NC or MERTK siRNA for 48 h, and CCT5 expression was analyzed by Western blotting. (D) HsRPE cells were treated the same as in (C), and cell proliferation was determined by CCK8 assay. (E) HsRPE cells were treated the same as in (C) , and morphological changes were observed using an inverted microscope. Scale bars: 100 μm. (F) HsRPE cells were treated the same as in (C) , and wound-healing assays were performed to assess the wound-healing capabilities of HsRPE cells. Scale bars: 200 μm. (G) HsRPE cells were treated the same as in (C) , and Transwell assays were performed to evaluate the migration activity of HsRPE cells (purple). Scale bars: 100 μm. # P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001.

    Article Snippet: The siRNAs for MERTK and CCT5 were designed and synthesized by RiboBio Inc. (Guangzhou, China).

    Techniques: Expressing, Migration, Reverse Transcription Polymerase Chain Reaction, Western Blot, CCK-8 Assay, Inverted Microscopy, Activity Assay

    CCT5 rescued the phagocytic function disrupted by MERTK siRNA by restoring the expression and organization of F-actin in HsRPE cells. (A) HsRPE cells were treated with or without CCT5 siRNA or CCT5 -Le after exposure to NC or MERTK siRNA for 48 h, and the phagocytic ability of HsRPE cells was examined by phagocytosis assay. The red dots represent the particles and the green dye represents the CCT5 protein. Scale bars: 5 μm. (B) HsRPE cells were treated with or without CCT5 siRNA or CCT5 -Le after exposure to NC or MERTK siRNA for 24 h, and F-actin expression was analyzed by RT-PCR. (C) HsRPE cells were treated the same as in (A), and F-actin expression was analyzed by Western blotting. (D) HsRPE cells were treated the same as in (A), and the distribution and organization of F-actin (green) were detected by immunofluorescence analysis. Scale bars: 10 μm. # P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001.

    Journal: Frontiers in Medicine

    Article Title: Chaperonin-Containing TCP1 Subunit 5 Protects Against the Effect of Mer Receptor Tyrosine Kinase Knockdown in Retinal Pigment Epithelial Cells by Interacting With Filamentous Actin and Activating the LIM-Kinase 1/Cofilin Pathway

    doi: 10.3389/fmed.2022.861371

    Figure Lengend Snippet: CCT5 rescued the phagocytic function disrupted by MERTK siRNA by restoring the expression and organization of F-actin in HsRPE cells. (A) HsRPE cells were treated with or without CCT5 siRNA or CCT5 -Le after exposure to NC or MERTK siRNA for 48 h, and the phagocytic ability of HsRPE cells was examined by phagocytosis assay. The red dots represent the particles and the green dye represents the CCT5 protein. Scale bars: 5 μm. (B) HsRPE cells were treated with or without CCT5 siRNA or CCT5 -Le after exposure to NC or MERTK siRNA for 24 h, and F-actin expression was analyzed by RT-PCR. (C) HsRPE cells were treated the same as in (A), and F-actin expression was analyzed by Western blotting. (D) HsRPE cells were treated the same as in (A), and the distribution and organization of F-actin (green) were detected by immunofluorescence analysis. Scale bars: 10 μm. # P > 0.05; * P < 0.05; ** P < 0.01; *** P < 0.001.

    Article Snippet: The siRNAs for MERTK and CCT5 were designed and synthesized by RiboBio Inc. (Guangzhou, China).

    Techniques: Expressing, Phagocytosis Assay, Reverse Transcription Polymerase Chain Reaction, Western Blot, Immunofluorescence

    CCT5 rescued HsRPE cells with MERTK-associated RP via the LIMK1/cofilin, but not the SSH1/cofilin, pathway. (A) HsRPE cells were treated with or without CCT5 siRNA or CCT5 -Le after exposure to NC or MERTK siRNA for 48 h, and the cofilin and p-cofilin expression was analyzed by Western blotting. (B) HsRPE cells were treated the same as in (A) , and the expression of LIMK1, TESK1, and SSH1 was analyzed by Western blotting. * P < 0.05; ** P < 0.01; *** P < 0.001.

    Journal: Frontiers in Medicine

    Article Title: Chaperonin-Containing TCP1 Subunit 5 Protects Against the Effect of Mer Receptor Tyrosine Kinase Knockdown in Retinal Pigment Epithelial Cells by Interacting With Filamentous Actin and Activating the LIM-Kinase 1/Cofilin Pathway

    doi: 10.3389/fmed.2022.861371

    Figure Lengend Snippet: CCT5 rescued HsRPE cells with MERTK-associated RP via the LIMK1/cofilin, but not the SSH1/cofilin, pathway. (A) HsRPE cells were treated with or without CCT5 siRNA or CCT5 -Le after exposure to NC or MERTK siRNA for 48 h, and the cofilin and p-cofilin expression was analyzed by Western blotting. (B) HsRPE cells were treated the same as in (A) , and the expression of LIMK1, TESK1, and SSH1 was analyzed by Western blotting. * P < 0.05; ** P < 0.01; *** P < 0.001.

    Article Snippet: The siRNAs for MERTK and CCT5 were designed and synthesized by RiboBio Inc. (Guangzhou, China).

    Techniques: Expressing, Western Blot

    The model diagram of CCT5 -specific lentiviral vectors ( CCT5 -Le) rescued the cell phagocytic function of HsRPE cells under MERTK siRNA condition by increasing the expression of F-actin and restoring its regular arrangement via the LIMK1/cofilin pathway.

    Journal: Frontiers in Medicine

    Article Title: Chaperonin-Containing TCP1 Subunit 5 Protects Against the Effect of Mer Receptor Tyrosine Kinase Knockdown in Retinal Pigment Epithelial Cells by Interacting With Filamentous Actin and Activating the LIM-Kinase 1/Cofilin Pathway

    doi: 10.3389/fmed.2022.861371

    Figure Lengend Snippet: The model diagram of CCT5 -specific lentiviral vectors ( CCT5 -Le) rescued the cell phagocytic function of HsRPE cells under MERTK siRNA condition by increasing the expression of F-actin and restoring its regular arrangement via the LIMK1/cofilin pathway.

    Article Snippet: The siRNAs for MERTK and CCT5 were designed and synthesized by RiboBio Inc. (Guangzhou, China).

    Techniques: Expressing

    List of siRNA sequences.

    Journal: Frontiers in Medicine

    Article Title: Chaperonin-Containing TCP1 Subunit 5 Protects Against the Effect of Mer Receptor Tyrosine Kinase Knockdown in Retinal Pigment Epithelial Cells by Interacting With Filamentous Actin and Activating the LIM-Kinase 1/Cofilin Pathway

    doi: 10.3389/fmed.2022.861371

    Figure Lengend Snippet: List of siRNA sequences.

    Article Snippet: The siRNAs for MERTK and CCT5 were designed and synthesized by RiboBio Inc. (Guangzhou, China).

    Techniques:

    Sequences of PCR primers.

    Journal: Frontiers in Medicine

    Article Title: Chaperonin-Containing TCP1 Subunit 5 Protects Against the Effect of Mer Receptor Tyrosine Kinase Knockdown in Retinal Pigment Epithelial Cells by Interacting With Filamentous Actin and Activating the LIM-Kinase 1/Cofilin Pathway

    doi: 10.3389/fmed.2022.861371

    Figure Lengend Snippet: Sequences of PCR primers.

    Article Snippet: The siRNAs for MERTK and CCT5 were designed and synthesized by RiboBio Inc. (Guangzhou, China).

    Techniques:

    Sequences of the lentiviral vectors of  CCT5.

    Journal: Frontiers in Medicine

    Article Title: Chaperonin-Containing TCP1 Subunit 5 Protects Against the Effect of Mer Receptor Tyrosine Kinase Knockdown in Retinal Pigment Epithelial Cells by Interacting With Filamentous Actin and Activating the LIM-Kinase 1/Cofilin Pathway

    doi: 10.3389/fmed.2022.861371

    Figure Lengend Snippet: Sequences of the lentiviral vectors of CCT5.

    Article Snippet: The siRNAs for MERTK and CCT5 were designed and synthesized by RiboBio Inc. (Guangzhou, China).

    Techniques: